Table 9.
Surgical approach for FST of uterine sarcomas.
| Sarcoma | Patients, n | Laparotomic Myomectomy, n (%) | Laparoscopic Myomectomy, n (%) |
Hysteroscopic Myomectomy/Tumor resection, n (%) | Cervical Excision/LEEP, n (%) | Trachelectomy | Other/Not Specified, n (%) |
|---|---|---|---|---|---|---|---|
| LG-ESS | 63 | 13 (21) | 13 (21) | 12 (18) | 0 | 0 | 25 (40) |
| Adenosarcoma | 19 | 0 | 0 | 16 (84) | 2 (11) | 0 | 1 (5) |
| STUMP | 84 | 26 (31) | 2 (2) | 1 (1) | 0 | 0 | 55 (66) |
| LMS | 7 | 0 | 0 | 0 | 0 | 0 | 7 (100) |
| UTROSCT | 2 | 1 (50) | 0 | 0 | 0 | 0 | 1 (50) |
| Embryonal RMS of uterine cervix | 35 | 0 | 0 | 0 | 24 (68) | 8 (23) | 3 (9) |
| Total | 210 | 40 (19) | 15 (7) | 29 (14) | 26 (12) | 8 (4) | 92 (44) |
FST: fertility-sparing treatment; LEEP: loop electrosurgical excision procedure; LG-ESS: low-grade endometrial stromal sarcoma; LMS: leiomyosarcoma; n: number; RMS: rhabdomyosarcoma; STUMP: smooth muscle tumor of uncertain malignant potential; UTROSCT: uterine tumor resembling ovarian sex cord tumor.